Technical Analysis for VCYT - Veracyte, Inc.

Grade Last Price % Change Price Change
grade A 24.46 1.24% 0.30
VCYT closed up 1.24 percent on Friday, March 22, 2019, on 2.29 times normal volume. The bulls were able to push the stock to a new 52-week high. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical VCYT trend table...

Date Alert Name Type % Chg
Mar 22 New 52 Week Closing High Bullish 0.00%
Mar 22 Pocket Pivot Bullish Swing Setup 0.00%
Mar 22 New 52 Week High Strength 0.00%
Mar 22 Upper Bollinger Band Walk Strength 0.00%
Mar 22 Above Upper BB Strength 0.00%
Mar 22 Overbought Stochastic Strength 0.00%
Mar 22 Up 3 Days in a Row Strength 0.00%
Mar 22 Up 4 Days in a Row Strength 0.00%
Mar 22 Up 5 Days in a Row Strength 0.00%
Mar 22 Upper Bollinger Band Touch Strength 0.00%

Older signals for VCYT ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Veracyte, Inc. operates as a diagnostics company in the field of molecular cytology to enhance patient outcomes and lower healthcare costs. It provides Afirma Thyroid FNA Analysis, a solution that consists of its Gene Expression Classifier (GEC), which helps physicians in reducing unnecessary diagnostic surgeries for patients with thyroid nodules. The company is also developing Afirma Malignant GEC test for rare forms of thyroid cancer or metastases to the thyroid that is intended to inform surgical strategy; and idiopathic pulmonary fibrosis and nodules suspicious products for lung cancer. It serves endocrinologists, radiologists, and head and neck specialists. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
Organ Systems Gene Expression Lung Cancer Surgeries Idiopathic Pulmonary Fibrosis Glands Lower Healthcare Costs Thyroid Thyroid Cancer
Is VCYT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 24.95
52 Week Low 5.32
Average Volume 590,299
200-Day Moving Average 13.1876
50-Day Moving Average 19.1363
20-Day Moving Average 21.136
10-Day Moving Average 21.976
Average True Range 0.9789
ADX 33.44
+DI 39.9475
-DI 10.829
Chandelier Exit (Long, 3 ATRs ) 22.0133
Chandelier Exit (Short, 3 ATRs ) 21.3667
Upper Bollinger Band 23.9482
Lower Bollinger Band 18.3238
Percent B (%b) 1.09
BandWidth 26.610522
MACD Line 1.2743
MACD Signal Line 0.9894
MACD Histogram 0.2849
Fundamentals Value
Market Cap 829.03 Million
Num Shares 33.9 Million
EPS -0.80
Price-to-Earnings (P/E) Ratio -30.58
Price-to-Sales 3.94
Price-to-Book 5.91
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 26.08
Resistance 3 (R3) 26.06 25.51 25.81
Resistance 2 (R2) 25.51 25.09 25.52 25.72
Resistance 1 (R1) 24.98 24.84 25.25 25.00 25.63
Pivot Point 24.43 24.43 24.56 24.44 24.43
Support 1 (S1) 23.90 24.01 24.17 23.92 23.29
Support 2 (S2) 23.35 23.76 23.36 23.20
Support 3 (S3) 22.82 23.35 23.11
Support 4 (S4) 22.84